Therapeutic resolution of Myodysplastic Syndrome (MDS)
Pharmacology and Experimental Therapeutics
Dr T Nasim, Dr K Pors
Applications accepted all year round
Myelodysplastic syndromes (MDS) are the most common adult myeloid malignancy in the UK and it has been estimated that around 8,000 and 40,000 new cases are diagnosed each year in the UK and USA, respectively.